Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print October 5, 2005, doi:10.1212/01.wnl.0000184579.23624.6b)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
01.wnl.0000184579.23624.6bv1
65/11/1759    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heyer, E. J.
Right arrow Articles by Connolly, E. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heyer, E. J.
Right arrow Articles by Connolly, E. S., Jr
Related Collections
Right arrow Stroke prevention
Right arrow All Neuropsychology/Behavior
Right arrow All Cerebrovascular disease/Stroke
Right arrow Risk factors in epidemiology
NEUROLOGY 2005;65:1759-1763
© 2005 American Academy of Neurology

APOE-{varepsilon}4 predisposes to cognitive dysfunction following uncomplicated carotid endarterectomy

E. J. Heyer, MD, PhD, D. A. Wilson, BS, D. H. Sahlein, MD, J. Mocco, MD, S. C. Williams, BS, R. Sciacca, EngScD, A. Rampersad, BA, R. J. Komotar, MD, J. Zurica, BA, A. Benvenisty, MD, D. O. Quest, MD, G. Todd, MD, R. A. Solomon, MD and E. S. Connolly, Jr, MD

From the Departments of Neurological Surgery (Drs. Mocco, Komotar, Quest, Solomon, and Connolly, and D.A. Wilson and S.C. Williams), Anesthesiology (Dr. Heyer, and A. Rampersad and J. Zurica), Neurology (Dr. Heyer), and Medicine (Dr. Sciacca), Columbia University, New York, NY; Department of Surgery (Drs. Benvenisty and Todd), Division of Vascular Surgery, Saint Luke’s Roosevelt Hospital, New York, NY; Department of Radiology (Dr. Sahlein), New York University, New York.

Address correspondence and reprint requests to Dr. Ricardo J. Komotar, Department of Neurosurgery, Columbia University, 630 West 168th Street, Room 5-454, New York, NY 10032; e-mail: rjk2103{at}columbia.edu

Background: Between 9% and 23% of patients undergoing otherwise uncomplicated carotid endarterectomy (CEA) develop subtle cognitive decline 1 month postoperatively. The APOE-{varepsilon}4 allele has been associated with worse outcome following stroke.

Objective: To investigate the ability of APOE-{varepsilon}4 to predict post-CEA neurocognitive dysfunction.

Methods: Seventy-five patients with CEA undergoing elective CEA were prospectively recruited in this nested cohort study and demographic variables were recorded. Patients were evaluated before and 1 month after surgery with a standard battery of five neuropsychological tests. APOE genotyping was performed by restriction fragment length polymorphism analysis in all patients. Neuropsychological deficits were identified by comparing changes (before to 1 month post-operation) in individual performance on the test battery. Logistic regression was performed for APOE-{varepsilon}4 and previously identified risk factors.

Results: Twelve of 75 (16%) CEA patients possessed the APOE-{varepsilon}4 allele. Eight of 75 (11%) patients experienced neurocognitive dysfunction on postoperative day 30. One month post-CEA, APOE-{varepsilon}4–positive patients were more likely to be cognitively injured (42%) than APOE-{varepsilon}4–negative patients (5%) (p = 0.002). In multivariate analysis, the presence of the APOE-{varepsilon}4 allele increased the risk of neurocognitive dysfunction at 1 month 62-fold (62.28, 3.15 to 1229, p = 0.007). Diabetes (51.42, 1.94 to 1363, p = 0.02), and obesity (24.43, 1.41 to 422.9, p = 0.03) also predisposed to injury.

Conclusion: The APOE-{varepsilon}4 allele is a robust independent predictor of neurocognitive decline 1 month following CEA.

This article was previously published in electronic format as an Expedited E-Pub on October 5, 2005, at www.neurology.org.

This study was supported in part by the Irving Center for Clinical Research at Columbia University Medical Center. J.M. was supported in part by the Congress of Neurologic Surgeons Wilder Penfield Clinical Research Fellowship. D.A.W. was supported in part by the Doris Duke Clinical Research Fellowship. R.J.K. was supported in part by an NIH Research Training Fellowship. E.J.H. and E.S.C. were supported in part by a grant from the NIA (RO1 AG17604).

Disclosure: The authors report no conflicts of interest.

Received May 16, 2005. Accepted in final form August 23, 2005.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
C. W. Hogue, R. Fucetola, T. Hershey, K. Freedland, V. G. Davila-Roman, A. M. Goate, and R. E. Thompson
Risk factors for neurocognitive dysfunction after cardiac surgery in postmenopausal women.
Ann. Thorac. Surg., August 1, 2008; 86(2): 511 - 516.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
W. A. Kofke, P. A. Blissitt, H. Rao, J. Wang, K. Addya, and J. Detre
Remifentanil-Induced Cerebral Blood Flow Effects in Normal Humans: Dose and ApoE Genotype
Anesth. Analg., July 1, 2007; 105(1): 167 - 175.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
E. R. Marcantonio, J. L. Rudolph, D. Culley, G. Crosby, D. Alsop, and S. K. Inouye
Review Article: Serum Biomarkers for Delirium
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2006; 61(12): 1281 - 1286.
[Abstract] [Full Text] [PDF]

Home page
 JWatch NeurologyHome page
Is APOE a Risk Factor for Cerebrovascular Injury?
Journal Watch Neurology, February 9, 2006; 2006(209): 6 - 6.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.